CA2083177C - Alveolar surfactant proteins - Google Patents

Alveolar surfactant proteins Download PDF

Info

Publication number
CA2083177C
CA2083177C CA002083177A CA2083177A CA2083177C CA 2083177 C CA2083177 C CA 2083177C CA 002083177 A CA002083177 A CA 002083177A CA 2083177 A CA2083177 A CA 2083177A CA 2083177 C CA2083177 C CA 2083177C
Authority
CA
Canada
Prior art keywords
val
leu
gly
ile
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002083177A
Other languages
English (en)
French (fr)
Other versions
CA2083177A1 (en
Inventor
Bradley J. Benson
Robert T. White
Douglas I. Buckley
Robert M. Scarborough
James W. Schilling, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of CA2083177A1 publication Critical patent/CA2083177A1/en
Application granted granted Critical
Publication of CA2083177C publication Critical patent/CA2083177C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002083177A 1990-05-17 1991-05-17 Alveolar surfactant proteins Expired - Lifetime CA2083177C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/524,360 US5104853A (en) 1984-12-11 1990-05-17 Alveolar surfactant proteins having cys to ser mutations
US524,360 1990-05-17
PCT/US1991/003490 WO1991018015A1 (en) 1990-05-17 1991-05-17 Alveolar surfactant proteins

Publications (2)

Publication Number Publication Date
CA2083177A1 CA2083177A1 (en) 1991-11-18
CA2083177C true CA2083177C (en) 2002-02-26

Family

ID=24088871

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002083177A Expired - Lifetime CA2083177C (en) 1990-05-17 1991-05-17 Alveolar surfactant proteins

Country Status (5)

Country Link
US (1) US5104853A (cg-RX-API-DMAC7.html)
EP (1) EP0538273A4 (cg-RX-API-DMAC7.html)
JP (3) JPH05509301A (cg-RX-API-DMAC7.html)
CA (1) CA2083177C (cg-RX-API-DMAC7.html)
WO (1) WO1991018015A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995141B1 (en) 1990-04-04 2006-02-07 Vertex Pharmaceuticals Incorporated Interleukin 1β protease and interleukin 1β protease inhibitors
RU2206611C2 (ru) * 1991-08-30 2003-06-20 Вертекс Фармасьютикалз Инкорпорейтед ФРАГМЕНТ ДНК, ПЛАЗМИДНЫЙ ВЕКТОР, СПОСОБ ПОЛУЧЕНИЯ ПОЛИПЕПТИДА И ПОЛИПЕПТИД, ОБЛАДАЮЩИЙ IL-1β ПРОТЕАЗНОЙ АКТИВНОСТЬЮ
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US6143405A (en) * 1998-06-30 2000-11-07 3M Innovative Properties Company Light colored, electrically conductive coated particles and composites made therefrom
US6395149B1 (en) 1998-06-30 2002-05-28 3M Innovative Properties Company Method of making light colored, electrically conductive coated particles
WO2000005585A1 (en) 1998-07-24 2000-02-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Determination of the hydrophobic pulmonary surfactant protein sp-c
IT1308180B1 (it) 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
AU5074400A (en) 1999-06-17 2001-01-09 Byk Gulden Lomberg Chemische Fabrik Gmbh Surfactant protein c esters
WO2001019392A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
ES2346048T3 (es) 2001-10-11 2010-10-08 Nycomed Gmbh Nueva utilizacion de un agente tensioactivo pulmonar.
CA2575513C (en) 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
AU2009324637B2 (en) 2008-12-10 2016-09-08 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
JP7173452B2 (ja) * 2017-03-07 2022-11-16 キリンホールディングス株式会社 カルボキシル末端アミノ酸の分析方法
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
EP4136119A4 (en) * 2020-04-17 2024-09-11 Regeneron Pharmaceuticals, Inc. MODIFIED CCR POLYPEPTIDES AND USES THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
AU625394B2 (en) * 1987-11-04 1992-07-09 Byk Gulden Lomberg Chemische Fabrik Gmbh Alveolar surfactant proteins

Also Published As

Publication number Publication date
JP2005053929A (ja) 2005-03-03
WO1991018015A1 (en) 1991-11-28
EP0538273A4 (en) 1993-06-16
JP2002332298A (ja) 2002-11-22
CA2083177A1 (en) 1991-11-18
EP0538273A1 (en) 1993-04-28
US5104853A (en) 1992-04-14
JPH05509301A (ja) 1993-12-22

Similar Documents

Publication Publication Date Title
CA1340461C (en) Alveolar surfactant proteins
US5104853A (en) Alveolar surfactant proteins having cys to ser mutations
JP3459248B2 (ja) 合成肺界面活性ペプチド
US5164369A (en) Pulmonary surfactant protein and related polypeptide
RU2109749C1 (ru) Аналог инсулина, обладающий активностью снижения уровня глюкозы в крови
EP0251449B1 (en) Recombinant alveolar surfactant protein
IE83740B1 (en) Synthetic pulmonary surfactant peptides
CZ286976B6 (en) Polypeptides and pharmaceutical preparations containing thereof
JP3644035B2 (ja) 新規な合成ペプチド,それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤
JP5441904B2 (ja) 合成肺サーファクタントペプチド
US5385840A (en) DNA encoding analogs of human alveolar surfactant protein SP-5
HK1008744B (en) Alveolar surfactant proteins
HK1008744A1 (en) Alveolar surfactant proteins
JPH0279981A (ja) 成長因子活性を有する新規なポリペプチド及び該ポリペプチドをコードする核酸配列
US5430020A (en) Recombinant alveolar surfactant protein
WO1988005820A1 (en) Recombinant alveolar surfactant protein
DK173172B1 (da) Rekombinant overfladeaktivt alveolarprotein (ASP), rekombinant-DNA-sekvens kodende herfor, værtscelle transformeret med DNA
HK1005887B (en) Recombinant alveolar surfactant protein
NO875477L (no) Rekombinant alveolaert overflateaktivt protein.
NO177309B (no) Analogifremgangsmåte for fremstilling av et terapeutisk aktivt polypeptid

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry